Dishman Pharmaceuticals and Chemicals Ltd(Merged) - DISHMAN PHARMA. Share Price

Sector: Pharmaceuticals | ISIN: INE353G01020
₹ 301.20 (2.71%) icon29 May, 2017, 3:57:47 PM

Dishman Pharmaceuticals and Chemicals Ltd(Merged) KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 5/29/2017 3:57:47 PM

    ₹ 301.2 7.95 2.71
  • Open
  • ₹ 288.2
  • Prev. Close
  • ₹ 293.25
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 304.2
  • Day's Low
  • ₹ 278
  • 52 Week's High
  • ₹ 0
  • 52 Week's Low
  • ₹ 0
  • Book Value
  • ₹ 0
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 4,861.2
  • P/E
  • 200.7
  • EPS
  • 1.5
  • Divi. Yield
  • 0.33

Dishman Pharmaceuticals and Chemicals Ltd(Merged) Corporate Actions

No Record Found


Dishman Pharmaceuticals and Chemicals Ltd(Merged) News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Dishman Pharmaceuticals and Chemicals Ltd(Merged) SHAREHOLDING SNAPSHOT
16 April , 2024 | 09:34 PM

PROMOTER - TOTAL61.40%

Indian: 61.40%

Foreign: 0%

NON-PROMOTER - TOTAL 38.60%

Institutions: 20.84%

Non-Institutions: 17.76%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Dishman Pharmaceuticals and Chemicals Ltd(Merged) FINANCIALS

Dishman Pharmaceuticals and Chemicals Ltd(Merged) PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Dishman Pharmaceuticals and Chemicals Ltd(Merged)

  • JANMEJAY RAJNIKANT VYAS
  • Managing Director
  • DEOHOOTI JANMEJAY VYAS
  • Whole-time Director
  • ASHOK CHANDRAKANT GANDHI
  • Director
  • RAJENDRA SHANTILAL SHAH
  • Director
  • SANJAY SHAILESHBHAI MAJMUDAR
  • Director
  • ARPIT JANMEJAY VYAS
  • Managing Director & CFO
  • SUBIR KUMAR DAS
  • Director
  • MARK CHRISTOPHER GRIFFITHS
  • Director
  • SHRIMA GAURANGBHAI DAVE
  • Company Secretary

Summary

Dishman Pharmaceuticals and Chemicals Ltd is a recognized supplier of cost-effective, high quality chemical services and products to the global pharmaceutical and chemical industry. They are involved in the manufacture of active pharmaceutical ingredients (API), API intermediates, quaternary ammonium compounds and fine chemicals. They are having their manufacturing facility at Ahmedabad in Gujarat. Dishman Pharmaceuticals and Chemicals Ltd was incorporated in the year 1983 as a research-oriented organization. The company set up their first manufacturing unit in Naroda for phase Transfer Catalysts. The company earned the status of Quat Company by establishing themselves in the quat business.In the year 1995, the company formed a joint venture company with Schtz & Co, Germany called as Schutz Dishman Biotech Private Ltd. They manufacture Chlorhexidine Base, Chlorhexidine HCl, Chlorhexidine Acetate and Chlorhexidine Gluconate solution, for the European market. In the year 1997, the company commenced their production in the unit I at Bavla.In the year 1998, the company established marketing subsidiaries Dishman Europe in London and Dishman USA in Middlesex New Jersey. In the year 2001, they signed the first contract manufacturing project. The company converted their entire Bavla facility into 100% Export oriented Unit in the year 2003. Also, they acquired Chemconserve BV in Netherland.In April 2004, the company incorporated a wholly owned subsidiary company namely Dishman... Read More


Reports by Dishman Pharmaceuticals and Chemicals Ltd(Merged)


Reports by Dishman Pharmaceuticals and Chemicals Ltd(Merged)

Company FAQ

No Record Found